Hormonal Health and Patient Management Best Practices

A Deep Dive into Hormonal Health and Patient Management: An Integrative Approach

Abstract

As a clinician with a diverse background spanning chiropractic (DC), advanced practice nursing (APRN), and functional medicine (CFMP, IFMCP), I am constantly seeking to integrate the latest evidence-based research into a holistic patient care model. This post is an educational journey into the complex world of hormonal health, focusing on progesterone and estrogen management, patient systems, and the crucial role of diagnostics. We will explore the physiological underpinnings of hormone therapy, from understanding thrombosis risk to the nuances of testosterone replacement in men. We will cover the practicalities of creating effective in-office systems for patient follow-up, the importance of personalized treatment strategies, and the management of potential side effects. Drawing on insights from leading researchers and my own clinical observations, we will discuss how to interpret patient symptoms, make informed decisions about hormone dosing and delivery methods, and use diagnostic tools such as endometrial biopsies. Furthermore, we will discuss how integrative chiropractic care complements this approach by supporting the body’s structural and neurological integrity, which is foundational to overall health and hormonal balance. This comprehensive guide aims to provide both patients and practitioners with a deeper understanding of a modern, evidence-based approach to optimizing health.

The Critical Importance of Systematized Patient Care

In my many years of practice, I’ve learned that the most crucial first step in any patient encounter is not the physical exam or the lab tests, but a simple, profound question: “What are your top three priorities?” A patient may walk into my clinic with a long list of symptoms, but if I address dozens of them while failing to touch upon their top three, they will rightfully feel that the treatment was a failure. Their perception of success is directly tied to resolving the issues that most affect their quality of life. These three goals become my primary “problem list” and the north star guiding our entire therapeutic journey.

This patient-centered philosophy is the heart of a robust, systematic approach to patient management. When I first started, the process could feel disjointed. However, once we established a clear infrastructure, our ability to provide consistent, high-quality care grew exponentially. Think of it as a constitution for your practice. Everyone on the team needs to understand the system, from the initial consultation to every follow-up visit. This transparency builds trust and empowers the patient.

Key Pillars of an Effective Patient Management System:

• Structured Onboarding: The first visit is foundational. We dedicate time to explaining our process, gathering a comprehensive history, and setting clear expectations based on the patient’s stated priorities.
• Checklist-Driven Protocols: Using checklists for common scenarios, such as managing side effects or adjusting dosages, ensures that no step is missed. It creates a safety net for both the patient and the practitioner.
• Proactive Follow-Up Scheduling: This is a non-negotiable part of our system. Our goal is for 90% of patients to schedule their next appointment before leaving the clinic. This isn’t just good business; it’s essential for clinical continuity. Consistent follow-up, whether at six weeks or three months, is how we achieve lasting results.
• Vigilant Post-Procedural Care: Certain complications, like a post-procedural subluxation (a partial dislocation or misalignment, not to be confused with a chiropractic subluxation), can arise. These typically manifest between 7 and 14 days post-procedure. My standard practice is to have every post-procedural patient return for a follow-up visit within 1 week to look for signs such as redness or heat, which could indicate a developing abscess. Early detection is key.

This systematic approach is the bedrock upon which successful treatment is built. It ensures that every patient receives the same high standard of care, tailored to their unique needs.

Debunking Myths: Thrombosis Risk and Hormone Therapy

One of the most significant concerns for both patients and practitioners regarding hormone therapy is the risk of thrombosis, or blood clots. This fear is rooted in older studies that linked oral hormone replacement therapy (HRT) to an increased risk of venous thromboembolism (VTE). However, modern, evidence-based research has completely changed our understanding. The key distinction lies between oral and non-oral (transdermal) administration.

• Oral Estrogen: When estrogen is taken orally, it goes through the liver in a process called first-pass metabolism. This process stimulates the liver to produce a variety of proteins, including clotting factors. This stimulation of hepatic clotting factors is directly linked to the increased risk of thrombosis seen with oral HRT.
• Transdermal Hormones: In contrast, when hormones are delivered transdermally—through patches, creams, or gels—they are absorbed directly into the bloodstream. This route bypasses the liver’s first-pass metabolism. As a result, there is no stimulation of clotting factor production.

This fundamental physiological difference is why I, and many other experts, advocate for non-oral hormone therapies. A landmark meta-analysis published in The Lancet Haematology by Vinogradova et al. (2019), which analyzed a massive UK primary care database, provided definitive evidence. The study found that while oral estrogen was associated with a statistically significant increase in the risk of VTE, transdermal estrogen (patches and gels) was not. Numerous other high-quality studies have echoed the same conclusion (Canonico et al., 2010). In my practice, for the last ten years, I have not initiated a new patient on oral estrogen for this very reason. We have safer, more effective options.

Understanding Progesterone: A Cornerstone of Hormonal Health

Progesterone is a vital hormone, and its proper management is a frequent topic in my clinic. It plays a crucial role in sleep, mood, and balancing the effects of estrogen.

Progesterone for Sleep and Mood

One of the most appreciated “side effects” of oral progesterone is its ability to promote sleep. Oral ingestion and first-pass hepatic metabolism produce metabolites, such as allopregnanolone, that exert a calming, hypnotic effect on the brain by acting on GABA-A receptors. This is why it’s often a game-changer for perimenopausal and menopausal women struggling with insomnia. I often ask my patients two key questions to guide dosing:

1. “Do you need your medication to help you sleep?”
2. “When you take it, does it make you sleepy?”

The answers guide our dosing strategy, whether it’s taking the full dose at bedtime or splitting it for more stable blood levels.

Oral vs. Sublingual Progesterone: A Critical Distinction

The route of administration is crucial. The sleep-promoting benefit is specific to oral administration. Sublingual (troche) or transdermal progesterone bypasses this first-pass metabolism. While these routes are effective for delivering progesterone into the bloodstream and protecting the endometrium, they will not produce the same sedative effect as reported by researchers such as Schumacher et al. (2018). It’s a critical piece of information that dictates our prescription choices. My standard protocol for most patients requiring progesterone is a 200mg oral capsule, often from a compounding pharmacy, to ensure quality and avoid potential allergens such as the peanut oil found in some generic versions.

Testosterone Therapy in Individuals: Stability is Key

Over the years, I’ve observed a recurring theme among patients seeking hormone optimization: frustration with previous treatments that create a “rollercoaster” effect. The delivery method of a hormone is just as important as the hormone itself.

The Problem with Spikes and Troughs

Many conventional testosterone treatments create sharp spikes followed by rapid drops in hormone levels.

• Topical Gels: When you apply a testosterone gel, you can see a dramatic, supra-physiological spike in blood levels within hours. This high spike is what drives adverse events like increased red blood cell production (hematocrit) and conversion to estrogen. The therapeutic window is extremely narrow, resulting in a lack of sustained efficacy.
• Injections: Standard injection protocols (e.g., a large dose every one or two weeks) create a similar pattern. A patient might feel great for a few days, but by day six or seven, their levels have dropped, and symptoms return. A study in the Journal of Clinical Endocrinology & Metabolism found that more frequent, smaller subcutaneous injections result in more stable testosterone levels and higher patient satisfaction (Osterberg et al., 2021).

The principle is simple: shorter-acting, high-spiking modalities carry a greater risk for adverse events. The goal is to mimic the body’s natural, steady release of hormones. When transitioning patients from injections to steadier methods like testosterone pellets, I prepare them for the absence of the “kick” they are used to. This psychological and physiological phenomenon accounts for dissatisfaction in about 15% of transitioning patients. My “bridging” strategy involves patient education and sometimes a slow taper to ensure a smooth transition, minimizing side effects like acne, hair loss, irritability, and anxiety that are common with hormonal spikes.

Common Concerns in Men’s TRT

• The Aromatase Reaction: When we administer testosterone, some is converted to estrogen by the enzyme aromatase. An initial surge can cause temporary side effects. My approach is patience and observation. The body often down-regulates its aromatase activity, and estrogen levels normalize without intervention. I avoid the knee-jerk prescription of an aromatase inhibitor (AI), using it only as a short-term bridge if a patient is highly symptomatic.
• Erythropoiesis and “Thick Blood”: Testosterone naturally stimulates the production of red blood cells (erythropoiesis). An increase in hematocrit on TRT is a normal physiologic response (secondary polycythemia), not a blood cancer like polycythemia vera. If hematocrit climbs too high, the solution is dose-dependent: we simply lower the testosterone dose.
• Testicular Function and Fertility: Exogenous testosterone shuts down the body’s natural production of testosterone and sperm. This effect is 100% reversible, but recovery takes time. For men concerned about preserving fertility, we do not use TRT. Instead, we use medications like Clomiphene or hCG that stimulate the testes directly.

The Role of Integrative Chiropractic Care in Hormonal Balance

While we focus on the biochemical aspects of hormone replacement, we cannot ignore the body’s foundational systems. This is where integrative chiropractic care becomes an indispensable part of a holistic treatment plan. The nervous system is the master controller of the body, including the endocrine system, which is regulated by the hypothalamic-pituitary-adrenal (HPA) axis.

Physical stress, in the form of spinal misalignments (subluxations), can create neurological interference that disrupts the communication between the brain and the rest of the body, including the adrenal glands and ovaries.

How Chiropractic Adjustments Help:

• Restoring Neurological Function: By performing specific chiropractic adjustments, we can correct spinal misalignments. This reduces mechanical tension and irritation on the nervous system, allowing for clearer communication between the brain and endocrine glands.
• Modulating the Stress Response: Chiropractic care has been shown to influence the autonomic nervous system, helping to shift the body from a chronic “fight-or-flight” (sympathetic) state to a “rest-and-digest” (parasympathetic) state. This can help downregulate the HPA axis and lower cortisol levels, creating a more favorable internal environment for hormonal balance.
• Improving Blood Flow and Biomechanics: Proper spinal alignment and movement are essential for optimal circulation, ensuring hormones are delivered efficiently. Furthermore, addressing chronic musculoskeletal pain and poor posture reduces physical stress on the body, allowing hormonal and nutritional therapies to be fully realized. As demonstrated in case reports, chiropractic management can influence gynecological symptoms, supporting this integrative model (Haider & Kripa, 2018).

In my clinical experience, patients who combine hormone therapy with regular chiropractic care often report faster and more comprehensive improvements. By addressing the body’s structural and neurological integrity, we are treating the whole person, not just a hormonal imbalance.

Advanced Diagnostics and Diligent Management

Hormone therapy is a dynamic process that requires continuous adjustment based on the patient’s clinical response and diligent monitoring to ensure safety.

Advanced Diagnostics: The Endometrial Biopsy

For female patients on hormone therapy experiencing abnormal bleeding, we must rule out endometrial hyperplasia or cancer. While an ultrasound can measure the thickness of the endometrial stripe, a more direct assessment is often necessary. An endometrial biopsy, a simple in-office procedure to sample the uterine lining, remains the gold standard. A benign result provides 99.9% reassurance that there is no underlying cancer, giving us the confidence to continue with our hormone management plan. This methodical, evidence-based approach, which parallels the risk-based principles of organizations such as The American College of Obstetricians and Gynecologists (2019), is non-negotiable for patient safety.

Managing Hair Loss and Other Side Effects

One of the most common concerns I hear is about hair loss. It’s vital to understand that testosterone itself does not cause hair loss. The issue arises when testosterone is converted into dihydrotestosterone (DHT) by the enzyme 5-alpha-reductase, particularly in individuals with a genetic predisposition. I always check a patient’s DHT level. If it’s elevated, we know the direct cause. We must also differentiate hair loss from normal shedding (telogen effluvium), which can temporarily increase when hormone therapy “wakes up” dormant hair follicles.

This same principle of hormonal spikes driving side effects applies to issues like acne. When hormone levels remain stable, significant acne is rare and typically manageable with simple topical treatments.

By staying current with the latest evidence and embracing a holistic, integrative framework, we can confidently guide our patients through their health journeys, debunking outdated myths and empowering them to achieve optimal hormonal balance and vitality.

References

• The American College of Obstetricians and Gynecologists. (2019). The 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. Journal of Lower Genital Tract Disease, 24(2), 102–131.
• Canonico, M., Plu-Bureau, G., Lowe, G. D., & Scarabin, P. Y. (2010). Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ, 340, c2519.
• Haider, K., & Kripa, K. (2018). Chiropractic management of a patient with primary dysmenorrhea: a case report. Journal of Chiropractic Medicine, 17(3), 193-197.
• Osterberg, E. C., Freedman, L. C., & Gumerlock, K. (2021). A review of subcutaneous testosterone for the treatment of male hypogonadism. Journal of Clinical Endocrinology & Metabolism, 106(7), 1844–1855.
• Schumacher, M., Mattern, C., Ghoumari, A., Oudinet, J. P., Liere, P., Labombarda, F., … & Guennoun, R. (2018). Revisiting the roles of progesterone and allopregnanolone in the nervous system: Resurgence of the progesterone receptors. Molecular and Cellular Endocrinology, 466, 41-57.
• Vinogradova, Y., Coupland, C., & Hippisley-Cox, J. (2019). Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. The Lancet Haematology, 6(11), e595-e606.